Literature DB >> 17065241

Novel role for mast cells in omental tissue remodeling and cell recruitment in experimental peritoneal dialysis.

Mohammad Zareie1, Paolo Fabbrini, Liesbeth H P Hekking, Eelco D Keuning, Piet M Ter Wee, Robert H J Beelen, Jacob van den Born.   

Abstract

Because of its dynamic structure, the omentum plays a key role in the immunity of the peritoneal cavity by orchestrating peritoneal cell recruitment. Because mast cells accumulate in the omentum upon experimental peritoneal dialysis (PD) and may produce angiogenic/profibrotic factors, it was hypothesized that mast cells mediate omental tissue remodeling during PD. Daily treatment with conventional PD fluid (PDF) for 5 wk resulted in a strong omental remodeling response, characterized by an approximately 10-fold increase in mast cell density (P < 0.01), an approximately 20-fold increase in vessel density (P < 0.02), an approximately 20-fold increase in the number of milky spots (P < 0.01), and a four-fold increase in submesothelial matrix thickness (P < 0.0003) in wild-type rats. In contrast, all PDF-induced omental changes were significantly reduced in mast cell-deficient Ws/Ws rats or in wild-type rats that were treated orally with a mast cell stabilizer cromoglycate. A time-course experiment showed mast cell accumulation immediately before the formation of blood vessels and milky spots. Functionally, PDF evoked a peritoneal cell influx, which was significantly reduced in Ws/Ws rats (P < 0.04) and in wild-type rats that were treated with cromoglycate (P < 0.03). Cromoglycate treatment also completely prevented PDF-induced omental adhesions to the catheter tip (P = 0.0002). Mesothelial damage, angiogenesis, and fibrosis of mesentery and parietal peritoneum as well as glucose absorption rate and ultrafiltration capacity proved to be mast cell independent. Data strongly support the hypothesis that mast cells mediate PDF-induced omental tissue remodeling and, subsequently, peritoneal cell influx and adhesion formation, providing therapeutic possibilities of modulating omental function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17065241     DOI: 10.1681/ASN.2005111173

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  9 in total

1.  Developmental changes of mast cell populations in the cerebral meninges of the rat.

Authors:  Helen Michaloudi; Christos Batzios; Maria Chiotelli; Georgios C Papadopoulos
Journal:  J Anat       Date:  2007-09-06       Impact factor: 2.610

Review 2.  Pharmacologic targets and peritoneal membrane remodeling.

Authors:  Karima Farhat; Andrea W D Stavenuiter; Rob H J Beelen; Piet M Ter Wee
Journal:  Perit Dial Int       Date:  2014 Jan-Feb       Impact factor: 1.756

3.  Alterations in mast cell frequency and relationship to angiogenesis in the rat mammary gland during windows of physiologic tissue remodeling.

Authors:  Robert A Ramirez; Amy Lee; Pepper Schedin; Joshua S Russell; Patricia A Masso-Welch
Journal:  Dev Dyn       Date:  2012-05       Impact factor: 3.780

4.  Mast cells aggravate sepsis by inhibiting peritoneal macrophage phagocytosis.

Authors:  Albert Dahdah; Gregory Gautier; Tarik Attout; Frédéric Fiore; Emeline Lebourdais; Rasha Msallam; Marc Daëron; Renato C Monteiro; Marc Benhamou; Nicolas Charles; Jean Davoust; Ulrich Blank; Bernard Malissen; Pierre Launay
Journal:  J Clin Invest       Date:  2014-09-02       Impact factor: 14.808

5.  Neuropeptide release augments serum albumin loss and reduces ultrafiltration in peritoneal dialysis.

Authors:  Nicola Cavallini; Dick Delbro; Gunnar Tobin; Magnus Braide
Journal:  Perit Dial Int       Date:  2011-09-30       Impact factor: 1.756

6.  Investigation of the lower resistance meridian: speculation on the pathophysiological functions of acupuncture meridians.

Authors:  Weisheng Yang
Journal:  Evid Based Complement Alternat Med       Date:  2014-12-02       Impact factor: 2.629

7.  Quantitative Histomorphometry of the Healthy Peritoneum.

Authors:  Betti Schaefer; Maria Bartosova; Stephan Macher-Goeppinger; Akos Ujszaszi; Markus Wallwiener; Joanne Nyarangi-Dix; Peter Sallay; Dorothea Burkhardt; Uwe Querfeld; Viktoria Pfeifle; Bernd Lahrmann; Vedat Schwenger; Elke Wühl; Stefan Holland-Cunz; Franz Schaefer; Claus P Schmitt
Journal:  Sci Rep       Date:  2016-02-19       Impact factor: 4.379

8.  Mechanisms of Peritoneal Fibrosis: Focus on Immune Cells-Peritoneal Stroma Interactions.

Authors:  Michela Terri; Flavia Trionfetti; Claudia Montaldo; Marco Cordani; Marco Tripodi; Manuel Lopez-Cabrera; Raffaele Strippoli
Journal:  Front Immunol       Date:  2021-03-29       Impact factor: 7.561

Review 9.  IL-17A as a Potential Therapeutic Target for Patients on Peritoneal Dialysis.

Authors:  Vanessa Marchant; Antonio Tejera-Muñoz; Laura Marquez-Expósito; Sandra Rayego-Mateos; Raul R Rodrigues-Diez; Lucia Tejedor; Laura Santos-Sanchez; Jesús Egido; Alberto Ortiz; Jose M Valdivielso; Donald J Fraser; Manuel López-Cabrera; Rafael Selgas; Marta Ruiz-Ortega
Journal:  Biomolecules       Date:  2020-09-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.